(19)
(11) EP 1 480 677 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.04.2012 Bulletin 2012/16

(45) Mention of the grant of the patent:
29.02.2012 Bulletin 2012/09

(21) Application number: 02795068.2

(22) Date of filing: 20.11.2002
(51) International Patent Classification (IPC): 
A61K 47/06(2006.01)
A61K 9/08(2006.01)
 A61K 47/36(2006.01)
A61P 27/02(2006.01)
(86) International application number:
PCT/EP2002/013019
(87) International publication number:
WO 2003/043660 (30.05.2003 Gazette 2003/22)

(54)

COMPOSITION FOR STABILIZING HYALURONIC ACID

ZUSAMMENSETZUNG ZUR STABILISIERUNG VON HYALURONSÄURE

COMPOSITION DE STABILISATION DE L'ACIDE HYALURONIQUE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

(30) Priority: 21.11.2001 US 332042 P

(43) Date of publication of application:
01.12.2004 Bulletin 2004/49

(73) Proprietors:
  • Carl Zeiss Meditec SAS
    17180 Perigny (FR)
    Designated Contracting States:
    BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT 
  • Novartis Pharma GmbH
    1230 Wien (AT)
    Designated Contracting States:
    AT 

(72) Inventor:
  • TSAO, Fu-Pao
    Lawrenceville, GA 30043 (US)

(74) Representative: Lewitter, Herbert et al
Santarelli 14, Avenue de la Grande-Armée B.P. 237
75822 Paris Cedex 17
75822 Paris Cedex 17 (FR)


(56) References cited: : 
EP-A- 0 938 896
 US-A- 5 858 996
   
  • GOA K L ET AL: "HYALURONIC ACID A REVIEW OF ITS PHARMACOLOGY AND USE AS A SURGICAL AID IN OPHTHALMOLOGY, AND ITS THERAPEUTIC POTENTIAL IN JOINT DISEASE AND WOUND HEALING" DRUGS, ADIS INTERNATIONAL LTD, AT, vol. 47, no. 3, 1994, pages 536-566, XP009007356 ISSN: 0012-6667
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).